REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Apteka N27 OOO (Russia)

Main Activities: Pharmacies and Drug Stores
Full name: Apteka N27 OOO Profile Updated: September 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Russian Download a sample report

Apteka N27 OOO is based in Russia. The head office is in Rybinsk. The company operates in the Pharmacies and Drug Stores industry. It was incorporated on August 10, 2012. It currently has a total number of 38 (2022) employees. From the latest financial highlights, Apteka N27 OOO reported a net sales revenue drop of 4.26% in 2023. Its total assets grew by 4.21% over the same period. The net profit margin of Apteka N27 OOO increased by 0.18% in 2023.

Headquarters
Karyakinskaya, 47, IV
Rybinsk; Yaroslavl Oblast; Postal Code: 152931

Contact Details: Purchase the Apteka N27 OOO report to view the information.

Website: http://mnogotabletok.ru

Basic Information
Total Employees:
Purchase the Apteka N27 OOO report to view the information.
Outstanding Shares:
Purchase the Apteka N27 OOO report to view the information.
Registered Capital:
Purchase the Apteka N27 OOO report to view the information.
Incorporation Date:
August 10, 2012
Key Executives
Purchase this report to view the information.
General Director
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Subsidiaries
Nekommercheskaya Organizatsiya Rybinskaya Gorodskaya Farmatsevticheskaya Assotsiatsiya
Company Performance
Financial values in the chart are available after Apteka N27 OOO report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
-4.26%▼
Total operating revenue
-4.26%▼
Operating profit (EBIT)
-22.26%▼
Net Profit (Loss) for the Period
-1.23%▼
Total assets
4.21%▲
Total equity
7.78%▲
Operating Profit Margin (ROS)
-1.49%▼
Net Profit Margin
0.18%▲
Return on Equity (ROE)
-0.63%▼
Quick Ratio
6.04%▲
Cash Ratio
0.33%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo